Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese (ENDO)
This study has been terminated.
(Higher than anticipated rate of Hepatic abscess (N=7))
First Posted: November 16, 2012
Last Update Posted: February 1, 2017
Information provided by (Responsible Party):